• The company produced solid Q4 result and 2019 outlook, without exceeding expectations. The company introduced a second sensible acquisition increasing its wallet space of its customers offering them another product line. The company is a solid long-term prospect, although the shares are not cheap and there is not that much room for further valuation multiple expansion.

Source: SHU Portfolio: BioLife Solutions Marches On – BioLife Solutions, Inc. (NASDAQ:BLFS) | Seeking Alpha